Top scientists and Pfizer’s former CMO are backing Calidi Biotherapeutics (New York Stock Exchange American: $CLDI).
Why? Because its systemic genetic delivery platform could redefine how we treat cancer.
🎥 Watch our 30-sec investor overview.
🔗 https://t.co/NYi1wHkhLW
$CLDI $PFE $AMGN $JNJ $CADL $BMRN $CPRX $CGON $REPL $NBTX $IBRX
Top scientists and Pfizer’s former CMO are backing Calidi Biotherapeutics (New York Stock Exchange American: $CLDI).
Why? Because its systemic genetic delivery platform could redefine how we treat cancer.
🎥 Watch our 30-sec investor overview.
🔗 https://t.co/NYi1wHkhLW
$CLDI $PFE $AMGN $JNJ $CADL $BMRN $CPRX $CGON $REPL $NBTX $IBRX